110 related articles for article (PubMed ID: 14712934)
1. Computational vaccinology: quantitative approaches.
Flower DR; McSparron H; Blythe MJ; Zygouri C; Taylor D; Guan P; Wan S; Coveney PV; Walshe V; Borrow P; Doytchinova IA
Novartis Found Symp; 2003; 254():102-20; discussion 120-5, 216-22, 250-2. PubMed ID: 14712934
[TBL] [Abstract][Full Text] [Related]
2. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships.
Hattotuwagama CK; Doytchinova IA; Flower DR
Methods Mol Biol; 2007; 409():227-45. PubMed ID: 18450004
[TBL] [Abstract][Full Text] [Related]
3. Quantitative approaches to computational vaccinology.
Doytchinova IA; Flower DR
Immunol Cell Biol; 2002 Jun; 80(3):270-9. PubMed ID: 12067414
[TBL] [Abstract][Full Text] [Related]
4. In silico prediction of peptide binding affinity to class I mouse major histocompatibility complexes: a comparative molecular similarity index analysis (CoMSIA) study.
Hattotuwagama CK; Doytchinova IA; Flower DR
J Chem Inf Model; 2005; 45(5):1415-23. PubMed ID: 16180918
[TBL] [Abstract][Full Text] [Related]
5. New horizons in mouse immunoinformatics: reliable in silico prediction of mouse class I histocompatibility major complex peptide binding affinity.
Hattotuwagama CK; Guan P; Doytchinova IA; Flower DR
Org Biomol Chem; 2004 Nov; 2(22):3274-83. PubMed ID: 15534705
[TBL] [Abstract][Full Text] [Related]
6. Immunoinformatics and the prediction of immunogenicity.
Flower DR; Doytchinova IA
Appl Bioinformatics; 2002; 1(4):167-76. PubMed ID: 15130835
[TBL] [Abstract][Full Text] [Related]
7. Quantitative structure-activity relationships and the prediction of MHC supermotifs.
Doytchinova IA; Guan P; Flower DR
Methods; 2004 Dec; 34(4):444-53. PubMed ID: 15542370
[TBL] [Abstract][Full Text] [Related]
8. Toward the atomistic simulation of T cell epitopes automated construction of MHC: peptide structures for free energy calculations.
Todman SJ; Halling-Brown MD; Davies MN; Flower DR; Kayikci M; Moss DS
J Mol Graph Model; 2008 Feb; 26(6):957-61. PubMed ID: 17766153
[TBL] [Abstract][Full Text] [Related]
9. In silico quantitative prediction of peptides binding affinity to human MHC molecule: an intuitive quantitative structure-activity relationship approach.
Tian F; Yang L; Lv F; Yang Q; Zhou P
Amino Acids; 2009 Mar; 36(3):535-54. PubMed ID: 18575802
[TBL] [Abstract][Full Text] [Related]
10. Toward prediction of class II mouse major histocompatibility complex peptide binding affinity: in silico bioinformatic evaluation using partial least squares, a robust multivariate statistical technique.
Hattotuwagama CK; Toseland CP; Guan P; Taylor DJ; Hemsley SL; Doytchinova IA; Flower DR
J Chem Inf Model; 2006; 46(3):1491-502. PubMed ID: 16711768
[TBL] [Abstract][Full Text] [Related]
11. Quantitative online prediction of peptide binding to the major histocompatibility complex.
Hattotuwagama CK; Guan P; Doytchinova IA; Zygouri C; Flower DR
J Mol Graph Model; 2004 Jan; 22(3):195-207. PubMed ID: 14629978
[TBL] [Abstract][Full Text] [Related]
12. Predicting the affinity of epitope-peptides with class I MHC molecule HLA-A*0201: an application of amino acid-based peptide prediction.
Du QS; Wei YT; Pang ZW; Chou KC; Huang RB
Protein Eng Des Sel; 2007 Sep; 20(9):417-23. PubMed ID: 17681974
[TBL] [Abstract][Full Text] [Related]
13. Comparison between computational alanine scanning and per-residue binding free energy decomposition for protein-protein association using MM-GBSA: application to the TCR-p-MHC complex.
Zoete V; Michielin O
Proteins; 2007 Jun; 67(4):1026-47. PubMed ID: 17377991
[TBL] [Abstract][Full Text] [Related]
14. Physicochemical explanation of peptide binding to HLA-A*0201 major histocompatibility complex: a three-dimensional quantitative structure-activity relationship study.
Doytchinova IA; Flower DR
Proteins; 2002 Aug; 48(3):505-18. PubMed ID: 12112675
[TBL] [Abstract][Full Text] [Related]
15. POPI: predicting immunogenicity of MHC class I binding peptides by mining informative physicochemical properties.
Tung CW; Ho SY
Bioinformatics; 2007 Apr; 23(8):942-9. PubMed ID: 17384427
[TBL] [Abstract][Full Text] [Related]
16. Molecule kernels: a descriptor- and alignment-free quantitative structure-activity relationship approach.
Mohr JA; Jain BJ; Obermayer K
J Chem Inf Model; 2008 Sep; 48(9):1868-81. PubMed ID: 18767832
[TBL] [Abstract][Full Text] [Related]
17. Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations.
Durdagi S; Mavromoustakos T; Chronakis N; Papadopoulos MG
Bioorg Med Chem; 2008 Dec; 16(23):9957-74. PubMed ID: 18996019
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in immunoinformatics: application of in silico tools to drug development.
Evans MC
Curr Opin Drug Discov Devel; 2008 Mar; 11(2):233-41. PubMed ID: 18283611
[TBL] [Abstract][Full Text] [Related]
19. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
[TBL] [Abstract][Full Text] [Related]
20. Molecular docking and 3D QSAR studies on 1-amino-2-phenyl-4-(piperidin-1-yl)-butanes based on the structural modeling of human CCR5 receptor.
Xu Y; Liu H; Niu C; Luo C; Luo X; Shen J; Chen K; Jiang H
Bioorg Med Chem; 2004 Dec; 12(23):6193-208. PubMed ID: 15519163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
